MBNL1 and myotonic dystrophy type 1: Therefore, the recovery of endogenous MBNL1 function is necessary for effective DM1 therapies, and our quantitative methods investigating MBNL1-mediated pathology are promising for judging the potential of therapeutics for DM1.